Jupiter Financial Statements From 2010 to 2024

JUNS Stock  USD 9.73  1.13  10.41%   
Jupiter Neurosciences, financial statements provide useful quarterly and yearly information to potential Jupiter Neurosciences, Common investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Jupiter Neurosciences, financial statements helps investors assess Jupiter Neurosciences,'s valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Jupiter Neurosciences,'s valuation are summarized below:
Market Capitalization
200.2 M
There are over one hundred three available fundamental trends for Jupiter Neurosciences,, which can be analyzed over time and compared to other ratios. All traders should confirm Jupiter Neurosciences,'s regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Jupiter Neurosciences, Total Revenue

199,455

Check Jupiter Neurosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jupiter Neurosciences,'s main balance sheet or income statement drivers, such as Interest Expense of 298.9 K, Selling General Administrative of 2.8 M or Total Revenue of 199.5 K, as well as many indicators such as Price To Sales Ratio of 533, Dividend Yield of 0.0 or Days Sales Outstanding of 32.73. Jupiter financial statements analysis is a perfect complement when working with Jupiter Neurosciences, Valuation or Volatility modules.
  
Check out the analysis of Jupiter Neurosciences, Correlation against competitors.

Jupiter Neurosciences, Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets141.2 K148.6 K482.9 K
Slightly volatile
Short and Long Term Debt Total1.3 M2.2 M489.4 K
Slightly volatile
Other Current Liabilities3.5 M3.5 MM
Pretty Stable
Total Current Liabilities6.3 M5.8 M4.8 M
Slightly volatile
Accounts Payable177.1 K189.5 K239 K
Slightly volatile
Cash27.1 K28.5 K182.6 K
Slightly volatile
Cash And Short Term Investments27.1 K28.5 K182.6 K
Slightly volatile
Net Receivables101 K113.6 K123.7 K
Slightly volatile
Common Stock Shares Outstanding23.1 M37.8 M13.3 M
Slightly volatile
Liabilities And Stockholders Equity141.2 K148.6 K482.9 K
Slightly volatile
Other Current Assets248261166.9 K
Slightly volatile
Other Stockholder Equity12.1 M17.8 M7.7 M
Slightly volatile
Total Liabilities6.4 M5.9 M4.8 M
Slightly volatile
Total Current Assets27.3 K28.7 K442 K
Slightly volatile
Short Term Debt1.2 M2.1 M454 K
Slightly volatile
Common Stock1.8 K2.7 K977
Slightly volatile
Property Plant And Equipment Net130 K116.1 K194.4 K
Slightly volatile
Non Current Assets Total133 K119.9 K198.1 K
Slightly volatile
Non Currrent Assets OtherK3.4 K3.7 K
Slightly volatile
Non Current Liabilities Total169.4 K178 K162.7 K
Pretty Stable

Jupiter Neurosciences, Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense298.9 K218.7 K101.4 K
Slightly volatile
Selling General Administrative2.8 M2.9 M1.7 M
Slightly volatile
Total Revenue199.5 K210 K911.3 K
Slightly volatile
Gross Profit199.5 K210 K911.3 K
Slightly volatile
Other Operating Expenses4.1 M3.9 M3.3 M
Slightly volatile
Research Development997.3 K954.8 K1.5 M
Slightly volatile
Total Operating Expenses4.1 M3.9 M3.3 M
Slightly volatile
Income Tax Expense143.3 K161.3 K175.6 K
Slightly volatile

Jupiter Neurosciences, Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change To Inventory36 K40.5 K44.1 K
Slightly volatile
Stock Based Compensation1.1 M1.2 M658.7 K
Slightly volatile
Change In Working Capital1.6 M2.3 M1.2 M
Slightly volatile
Begin Period Cash Flow61.2 K64.4 K45.2 K
Slightly volatile
Other Cashflows From Financing Activities985.3 K1.5 M683.4 K
Slightly volatile
Total Cash From Financing Activities749.3 K445 K607.4 K
Slightly volatile
End Period Cash Flow27.1 K28.5 K182.6 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio533507134
Slightly volatile
Days Sales Outstanding32.7336.8240.0927
Slightly volatile
Average Payables235.5 K188.3 K200.5 K
Slightly volatile
Stock Based Compensation To Revenue1.63.151.0126
Slightly volatile
EV To Sales540514135
Slightly volatile
ROIC0.581.0540.6266
Slightly volatile
Sales General And Administrative To Revenue11.0310.513.408
Slightly volatile
Research And Ddevelopement To Revenue2.073.641.8701
Slightly volatile
Cash Per Share8.0E-49.0E-40.0043
Slightly volatile
Income Quality0.150.10050.1026
Slightly volatile
ROE0.540.82460.6283
Pretty Stable
Current Ratio0.00470.0050.0159
Slightly volatile
Receivables Turnover7.148.038.7436
Slightly volatile
Graham Number0.720.76011.819
Slightly volatile
Average Receivables50.5 K56.8 K61.9 K
Slightly volatile
Revenue Per Share0.00780.00820.1005
Slightly volatile
Interest Debt Per Share0.09150.07140.1386
Slightly volatile
Debt To Assets13.6114.3275133
Slightly volatile
Ebt Per Ebit0.971.23581.3077
Slightly volatile
Return On Capital Employed0.460.68830.4836
Slightly volatile
Quick Ratio0.00470.0050.0159
Slightly volatile
Net Income Per E B T0.830.941.0216
Slightly volatile
Cash Ratio0.00470.00490.0085
Slightly volatile
Days Of Sales Outstanding32.7336.8240.0927
Slightly volatile
Fixed Asset Turnover2.461.652.8128
Slightly volatile
Debt Ratio13.6114.3275133
Slightly volatile
Price Sales Ratio533507134
Slightly volatile
Asset Turnover1.461.141.8047
Slightly volatile
Return On Equity0.540.82460.6283
Pretty Stable

Jupiter Neurosciences, Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap144.4 M162.4 M176.9 M
Slightly volatile
Enterprise Value146.2 M164.4 M179.1 M
Slightly volatile

Jupiter Fundamental Market Drivers

Cash And Short Term Investments28.5 K

About Jupiter Neurosciences, Financial Statements

Jupiter Neurosciences, shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Jupiter Neurosciences, investors may analyze each financial statement separately, they are all interrelated. The changes in Jupiter Neurosciences,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Jupiter Neurosciences,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue210 K199.5 K
Stock Based Compensation To Revenue 3.15  1.60 
Sales General And Administrative To Revenue 10.51  11.03 
Research And Ddevelopement To Revenue 3.64  2.07 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(16.92)(16.07)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Jupiter Stock Analysis

When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.